<DOC>
	<DOCNO>NCT01703325</DOCNO>
	<brief_summary>Psoriatic nail significantly affect quality life patient . Psoriasis affect nail matrix nail bed . Pitting , leukonychia red spot lunula indicate defect nail matrix . Psoriasis change nail bed result onycholysis , discoloration , splinter hemorrhage subungual hyperkeratosis . The main treatment psoriatic nail use topical high- potent steroid however topical steroid limit ability penetrate deep nail matrix nail bed main pathology . Use treatment lead skin atrophy report case `` Disappearing digit '' . Previous study steroid injection treatment psoriatic nail show satisfactory result without serious permanent adverse effect . At present , comparison study intralesional steroid ultrapotent topical steroid treatment psoriatic nail . The purpose study evaluate efficacy safety intralesional triamcinolone compare 0.05 % clobetasol ointment treatment psoriatic nail .</brief_summary>
	<brief_title>Comparison Efficacy Intralesional Triamcinolone Injection Clobetasol Propionate Ointment Psoriatic Nails</brief_title>
	<detailed_description>Psoriasis chronic inflammatory disorder . The nails involvement report 40 % psoriatic patient . Psoriatic nail significantly affect quality life patient . Psoriasis affect nail matrix nail bed . Pitting , leukonychia red spot lunula indicate defect nail matrix . Psoriasis change nail bed result onycholysis , discoloration , splinter hemorrhage subungual hyperkeratosis . The main treatment psoriatic nail use topical high- potent steroid however topical steroid limit ability penetrate deep nail matrix nail bed main pathology . Use treatment lead skin atrophy report case `` Disappearing digit '' . Previous study steroid injection treatment psoriatic nail show satisfactory result without serious permanent adverse effect . At present , comparison study intralesional steroid ultrapotent topical steroid treatment psoriatic nail . The purpose study evaluate efficacy safety intralesional triamcinolone compare 0.05 % clobetasol ointment treatment psoriatic nail .</detailed_description>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Clobetasol</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>Subjects age 18 year old least 3 psoriatic finger nail resembly severity 1 . Patients receive systemic therapy psoriasis 2 . Patients discontinued systemic therapy le 3 month topical therapy le 1 month 3 . Positive result microscopic study fungus finger nail 4 . History steroid EMLA allergy 5 . Pregnancy nurse 6 . Any skin infection site treatment 7 . Human immunodeficiency virus subject 8 . History malignancy treatment malignancy 9 . Patients psychological disorder 10 . Patients bleed disorder receive anticoagulation drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Psoriatic nail</keyword>
	<keyword>Triamcinolone injection</keyword>
	<keyword>clobetasol propionate</keyword>
</DOC>